EPIX - ESSA Pharma GAAP EPS of -$0.25

ESSA Pharma press release (NASDAQ:EPIX): Q2 GAAP EPS of -$0.25. At March 31, 2022, the Company had available cash reserves and short-term investments of $181.0 million reflecting the gross proceeds of the February 2021 financing of approximately $150.0 million and July 2020 financing of $48.9 million, less operating expenses in the intervening period.  The Company's cash position is expected to be sufficient to fund current and planned operations through 2024

For further details see:

ESSA Pharma GAAP EPS of -$0.25